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Abstract
Background: A meta-analysis concluded that there was no effect of the femoral head ossification and the
incidence of osteonecrosis in the treatment of developmental dysplasia of the hip (DDH), unless only osteonecrosis
grades II-IV were considered. The meta-analysis, limited due to the small number of studies available at that time,
identified a need for an update as further research emerges. We observed a trend in recent years towards delaying
treatment of DDH in the absence of an ossified nucleus. Numerous new publications on this topic encouraged us
to update the 2009 meta-analysis.
Methods: We performed a systematic review of the literature from 1967 to 2016 and included studies that
reported on the treatment of DDH, the ossific nucleus and osteonecrosis. Two independent reviewers evaluated all
articles. We performed a meta-analysis with the main outcome defined as the development of osteonecrosis of the
femoral head at least two years after closed or open reduction.
Results: Of four prospective and ten retrospective studies included in the systematic review, 11 studies (1,021
hips) met the inclusion criteria for the meta-analysis. There was no significant effect of the ossific nucleus on the
development of all grades of osteonecrosis (relative risk, 0.88; 95% confidence interval, 0.56–1.41) or osteonecrosis
grades II–IV (0.67; 0.41–1.08). In closed reductions, the ossific nucleus halved the risk for developing osteonecrosis
grades II–IV (0.50; 0.26–0.94).
Conclusions: Based on current evidence there does not appear to be a protective effect of the ossific nucleus on
the development of osteonecrosis. In contrast to the previous meta-analysis, this update demonstrates that this
remains the case irrespective of the grade of osteonecrosis considered relevant. This updated meta-analysis is based
on twice as many studies with a higher quality of evidence.
Background
Some surgeons believe that in the treatment of develop-
mental dysplasia of the hip (DDH), osteonecrosis may be
avoided by intentionally delaying a closed or open reduc-
tion until the appearance of the ossific nucleus [1–3].
Results of published studies remain inconsistent with
some authors advocating a protective effect of the ossific
nucleus [1, 3–5] and others demonstrating no effect [6–8].
A previous meta-analysis of six observational studies
[9] concluded that the presence of the ossific nucleus at
the time of hip reduction had a protective effect against
the development of grade II-IV osteonecrosis according
to Bucholz and Ogden [10] or Kalamchi and MacEwen
[11]. However, this effect was lost when osteonecrosis of
any grade was considered. It also showed that in closed
reductions an ossified nucleus reduced the risk of osteo-
necrosis by 60%, whereas no effect was seen in open
reductions. Due to the moderate quality of evidence, the
meta-analysis identified a need for further research [9].
With an increase in the number of studies seeking to
* Correspondence: rafal.niziol@nhs.net
This work was performed at Institute of Child Health University College
London and Great Ormond Street Hospital for Children, London, England.
Great Ormond Street Hospital for Children and UCL Institute of Child Health,
30 Guildford Street, London WC1N 3EH, UK
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Niziol et al. BMC Musculoskeletal Disorders  (2017) 18:165 
DOI 10.1186/s12891-017-1468-6
clarify the effect of the ossific nucleus [1–3, 5–8, 12–14]
we sought to update the meta-analysis.
This study aimed (i) to determine the effect of the
presence of the ossific nucleus on the development of
osteonecrosis and (ii) to assess whether the type of
reduction performed or the grade of osteonecrosis
considered relevant would affect the conclusion.
Methods
Search strategy
We updated a previous (1960–2007) systematic review
with an electronic search of the literature for the period
of May 2007 to November 2016. We identified articles
reporting on any association between the ossific nucleus
and osteonecrosis. In line with the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) statement [15], we included MEDLINE and
EMBASE databases and combined MeSH (Medical
Subject Headings) and EMBASE terms and free text
words in Dialog Data Star® including the terms ossific,
nucleus, hip and dislocation. We also searched the
DARE database and Cochrane Library.
Two reviewers (AR, RN) independently screened titles
and abstracts of eligible citations and determined if they
met the inclusion criteria. Selected articles were evalu-
ated independently and disagreements resolved in con-
sensus. In this process both reviewers demonstrated
substantial [6] agreement (kappa = 0.72).
Inclusion and exclusion criteria
This systematic review included studies of any design
reporting on (i) the presence or absence of the ossific nu-
cleus of the proximal femoral epiphysis on pre-reduction
radiographs or ultrasound and (ii) osteonecrosis as an
outcome of the treatment of DDH in children up to
18 years. We included studies which defined osteonecrosis
by radiographic criteria (Bucholz and Ogden [10] or
Kalamchi and MacEwen [11]). We excluded studies with a
follow-up of less than two years and studies reporting on
neuromuscular hip disorders, teratological hip dislocation
and septic arthritis [2, 4, 5, 7, 13, 14, 16]. We excluded
paper written in languages other than English, Polish and
German.
Data extraction and outcome measures
Two reviewers (AR, RN) independently extracted all
data relevant for systematic review and meta-analysis
with use of a data collection form [9], ensuring precise
collection of all relevant information. We resolved
disagreements in consensus.
We assessed the quality of evidence using the four
domains of the GRADE (Grading of Recommendations
Assessment, Development and Evaluation) statement [17]:
study design, study quality, consistency and directness. We
used clinical homogeneity as a criterion for pooling data
between studies. We defined clinically homogeneous stud-
ies as those with comparable populations, interventions
and outcomes measured at a similar time point. We also
tested for statistical homogeneity as described below.
Statistical analysis
We quantified agreement between reviewers with the
simple kappa statistic [18] and reported treatment ef-
fects as relative risks. We used the Q-test at the 10%
significance level to test for statistical homogeneity and
Higgins’ I2 statistic to determine the percentage of total
variation across studies due to heterogeneity [18].
RevMan 5.3 software was used to perform the meta-
analysis. We employed fixed effects model in cases of
statistical homogeneity (I2 < 50%) and random-effect
models if there was statistical heterogeneity. However,
we also performed additional fixed and random effects
models on all groups analysed for data comparison. We
performed subgroup analyses based on grade of osteo-
necrosis and based on closed and open reductions.
Funnel plots used to test publication bias were generated
using the RevMan 5.3 software.
Results
Search and selection
The electronic search revealed 97 studies (Fig. 1), of
which 69 studies did not meet the inclusion criteria as
per abstract review, resulting in 28 articles being evalu-
ated. We excluded another 14 studies: four studies failed
to comment on the ossific nucleus, five studies reported
on only patients with ossific nucleus or with osteonecro-
sis, five studies failed to present numbers for hips with
ossific nucleus and osteonecrosis. In total, we included
14 studies in this systematic review. Three studies com-
mented on the association between ossific nucleus and
osteonecrosis but could not be included in the meta-
analysis as they lacked detailed data [5, 13] or used a
case-control design [3].
The prevalence of osteonecrosis ranged from 6 to 48% across
the 14 studies. Nine studies (64%) [4, 6–8, 12–14, 16, 19]
showed no relationship between the ossific nucleus and
osteonecrosis; four studies (29%) [1–3, 5] claimed a
protective effect of the ossific nucleus and one study
(7%) [20] did not comment on a potential relationship.
Quality of evidence
We identified one prospective cohort study [12], eleven
retrospective cohort studies [1–4, 7, 8, 13, 14, 16, 19, 20],
and two case series [5, 6]. Eight studies (57%)
[1–3, 7, 8, 14, 16, 20] directly investigated the relation-
ship between the presence of the ossific nucleus and osteo-
necrosis. The remaining six studies (43%) [4–6, 12, 13, 19]
reported on this relationship without it being the
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primary objective of the research. Seven studies (50%)
[6, 8, 12–14, 19, 20] reported details about the sam-
pling frame. The remaining studies did not comment
on sampling. One study (7%) [20] analyzed a single-
surgeon’s series, seven studies (50%) [5, 7, 8, 12, 13, 16, 19]
included patients from two or more surgeons of the same
institution; the number of surgeons involved in the treat-
ment of included cases of DDH remained unclear in six
studies (43%) [1–3, 6, 14, 16].
We found consistency among all studies in that neuro-
muscular hip disease, teratological dislocation and cases
with missing imaging were not included. Other exclusion
criteria were failed surgical treatment prior to admission
[2, 4, 5, 7, 13, 14, 16] and postoperative septic arthritis
[13, 19]. There was inconsistency with regard to the
age threshold below which patients were excluded from
the research, namely no threshold [1, 3, 5–7, 12–14, 16],
one month [8], two months [20], three months [4, 11] and
six months [19]. Four studies (29%) limited the upper
age limit of patients included in the research to
18 months [8, 14], 20 months [20] or 24 months [4].
The number of participants in single studies varied
from 23 to 148, the average number being 67. There
were 166 cases of bilateral DDH (range, 0–38). The
mean age at hip reduction was 8.6 months (range, 0.7–
35). Four studies (29%) included patients treated by
closed reduction only, with a mean age at reduction of
8.9 months (range, 0.8-35) [1, 14, 16, 20]. Four studies
(29%) included patients treated by open reduction only,
with a mean age at reduction of 11.1 months (range, 2.4 –
24) [3–5, 12]. The remaining six studies (43%) included
patients undergoing either closed or open reduction, with
no age threshold stated for the preferred method of treat-
ment [2, 3, 7, 8, 13, 19].
Six studies (43%) [1, 7, 8, 12, 14, 16] presented the re-
lationship between the presence or absence of the ossific
nucleus and osteonecrosis in a two-by-two table and we
were able to extract this data from another five studies
(36%) [2, 4, 6, 19, 20]. Three studies (22%) commented
on statistical power in that they had 80% power to detect
differences of 20% [7], 24% [8] and 30% [13] in the
prevalence of osteonecrosis between patients with and
without an ossific nucleus (Table 1).
Confounders and effect modifiers
All studies identified age at reduction as a potential con-
founder; however only ten studies (72%) [1–3, 5–8, 12–14]
provided supportive statistical analyses. Two studies (14%)
[6, 14] found that hips reduced after the age of ten months
were more likely to develop osteonecrosis.
Carney et al. [1] found an increased risk of osteonecro-
sis when an adductor tenotomy was omitted during a
closed reduction (p = 0.007). Pospischill et al. [13] found
an increased risk for osteonecrosis if a concomitant oste-
otomy was done (p < 0.05).
The use of harness treatment, preoperative traction
and adductor tenotomy was not universal across all
studies. In ten studies (72%) [1–3, 6–8, 13, 14, 16, 20]
preoperative traction was employed. However, only five
studies (36%) [1, 3, 7, 8, 13] provided statistical
Database Search
May 2007 - November 2016
69 Citation(s)
97 Non-Duplicate
Citations Screened
Inclusion/Exclusion
Criteria Applied
Articles From Roposch et al 2009
1966 - April 2007
28 Citation(s)
69 Abstracts Excluded
28 Articles Retrieved
Inclusion/Exclusion
Criteria Applied
5 Articles Excluded
During Data Extraction
9 Articles Excluded
After Full Text Screen
14 Articles Included
Fig. 1 Flow diagram showing the search and selection process
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analyses and found no relationship between traction
and osteonecrosis.
Five studies (36%) [1, 3, 7, 8, 13] examined the effect
of failed harness treatment and osteonecrosis and no
such effect was seen.
Meta-analysis
A meta-analysis of 11 studies (1,021 hips) [1, 2, 4, 6–8,
12, 14, 16, 19, 20] showed no protective effect of the
ossific nucleus on the development of osteonecrosis
grades I-IV. 121/589 (21%) hips with an ossified nucleus
developed osteonecrosis compared with 75/432 (17%) in
the group without an ossific nucleus (relative risk, 0.87;
95% confidence interval, 0.55-1.38) (Fig. 2).
An analysis of osteonecrosis grades II–IV included
six studies (471 hips) [1, 2, 4, 7, 8, 12]. 33/303 (11%)
hips with an ossific nucleus developed osteonecrosis
compared with 30/168 (18%) without an ossific nucleus
(relative risk, 0.67; 95% confidence interval, 0.41-1.08)
(Fig. 3).
In 253 hips treated by closed reduction only, the ossific
nucleus reduced the risk for osteonecrosis of grades II-IV
by 50%. 14/153 (9%) hips with an ossific nucleus devel-
oped osteonecrosis compared with 20/100 (20%) in the
group without an ossific nucleus (relative risk, 0.50; 95%
confidence interval, 0.26-0.94) (Fig. 4). The reminder of
the subgroup analyses did not show significant effects
(Figs. 5, 6 and 7).
Publication bias
The generated Begg’s funnel plots showed points that
were evenly distributed and symmetrical (Fig. 8). This
shows that there is minimal publication bias and the
results of this meta-analysis are credible.
Discussion
Studies about the role of the femoral head ossific nucleus
in preventing osteonecrosis following treatment of DDH
reported conflicting results, but a 2009 meta-analysis
concluded that there was no such effect unless only
osteonecrosis grades II-IV were considered [9]. The meta-
analysis, limited due to the small number of studies avail-
able at that time, identified a need for an update as further
research emerges. We observed a trend in recent years
towards delaying treatment of DDH in the absence of an
ossified nucleus [1, 3, 21]. Numerous new publications on
this topic encouraged us to update the 2009 meta-analysis
in the hope to find robust conclusions.
With 11 studies or 1021 infants, this updated meta-
analysis included twice as many studies and three times
as many infants as the one published previously [9]. The
primary outcome, development of osteonecrosis of any
grade, remained similar with a relative risk of 0.75 (95%
Fig. 2 Forest plot for the development of osteonecrosis of any grade at two or more years following open or closed reduction. Including the
data of 11 studies, 1,021 hips were analyzed. There was no statistically significant association between the ossific nucleus and the development
of osteonecrosis
Fig. 3 Forest plot for the development of osteonecrosis of grade II or worse at two or more years following open or closed reduction. Including
the data of six studies there were 471 hips analyzed. There was no statistically significant association between the ossific nucleus and the
development of osteonecrosis
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confidence interval, 0.46–1.21) in the 2009 study, com-
pared with 0.87 (0.55–1.38) in the present study. We
used a random effects model to calculate the primary
outcome, as the I-squared value was greater than 50.
However, this resulted in a Tau-squared value of 0.27
which shows low heterogeneity between studies. We also
performed a fixed effects calculation on the same data
set in order to compare results, as the random effect
model assumes an average effect of the ossific nucleus
on osteonecrosis across all studies. This showed similar
results (Additional file 1). For the subgroup analysis we
used a fixed effect model as low heterogeneity between
studies was identified in the primary outcome meta-
analysis, the number of studies was small and we felt it
would be impossible to estimate the tau-squared value
with any precision. We suggest this is confirmatory
evidence that the ossified ossific nucleus does not play a
role in the prevention of osteonecrosis – there does not
seem to be a causal relationship.
The 2009 study showed a 60% reduction in the relative
risk for developing osteonecrosis grade II or worse if the
nucleus was ossified at the time of hip reduction (rela-
tive risk, 0.43, 95% confidence interval, 0.20–0.90) [9].
However, this subgroup analysis was based on only four
studies [9]. We were able to update this subgroup ana-
lysis by including two additional studies [4, 8], which
were of high quality based on the GRADE criteria. With
an increased sample size from 318 to 471 infants, the
updated result was no longer statistically significant –
there was no effect of the ossified nucleus on the devel-
opment of osteonecrosis grades II or worse. While the
upper bound of the 95% confidence interval for this ana-
lysis was 1.08, we suggest that with a point estimate of
0.67 and the relatively high quality of the additional
studies, this result is definitely negative.
The 2009 meta-analysis [9] also showed that the pres-
ence of the ossific nucleus reduced the probability of
grade I–IV osteonecrosis by 60% (relative risk = 0.41,
95% confidence interval, 0.18–0.91) after closed reduc-
tion. This conclusion was based on three available
studies or 183 infants. The updated analysis of closed re-
ductions included seven studies or 684 patients showed
no longer a protective effect with a relative risk of 0.80
(95% confidence interval, 0.38–1.69).
By contrast, infants treated with closed reductions
(253 hips from four studies) [1, 2, 7, 9] demonstrated a
50% reduction in risk of developing osteonecrosis grade
II-IV (relative risk, 0.50; 95% confidence interval, 0.26–
0.94). A possible explanation for this finding is that a
closed reduction performed on an ossified nucleus rep-
resents a lesser insult to a less plastic epiphysis [2, 3]. It
may be that during an open reduction the decreased
plasticity of the ossified nucleus is more than offset by
the trauma associated with surgery and possible disrup-
tion of the capsular blood supply.
We noticed inconsistencies in the reported prevalence
of osteonecrosis, which ranged from 6 to 48%. Those
studies that reported a prevalence of 6 to 7% [7, 14, 20]
included predominately cases of closed reductions.
Further, one study [7] excluded patients with incomplete
notes or imaging, and another study [20] excluded pa-
tients below the age of two months and those over
Fig. 4 Forest plot for the development of osteonecrosis of any grade II or worse at two or more years following closed reduction. Including the
data of four studies there were 253 hips analyzed. There was a statistically significant protective association between the ossific nucleus and the
development of osteonecrosis
Fig. 5 Forest plot for the development of osteonecrosis of grade II or worse at two or more years following open reduction. Including the data
of five studies there were 208 hips analyzed. There was no statistically significant association between the ossific nucleus and the development
of osteonecrosis
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20 month. Selection bias could possibly account for the
low prevalence of osteonecrosis in these studies. Meas-
urement bias is another possible explanation for the
wide range in prevalence estimates. Only seven studies
(50%) stated the number of outcome assessors [2, 8, 12–
14, 19, 20] and only two studies (14%) [8, 13] evaluated
outcomes blinded and included inter-rater reliability
studies. Attrition bias was inherent to the study of
Pospischill et al. [13], which excluded 21 patients (21%)
due to length of follow-up being less than three years.
All included studies identified the age at reduction as a
potential confounder in the relationship between osteo-
necrosis and an ossific nucleus; however, only ten studies
(72%) [1–3, 5–8, 12–14] provided supportive statistical
analyses. Other confounders have been reported: Carney
et al. [1] found an increased risk of osteonecrosis when an
adductor tenotomy was omitted as part of a closed reduc-
tion (p = 0.0066). In the study of Pospischill et al. [13]
osteonecrosis was more likely (p = 0.003) when a con-
comitant osteotomy was done. Only two studies (14%)
performed multivariate analyses [8, 13].
Our study has limitations. In four studies (29%) the
presence of the ossific nucleus was determined solely or
in select cases by ultrasound. Because previous research
has demonstrated that in 93% of cases an ossific nucleus
that is visible on ultrasound is also visible on radio-
graphs [22] we included these papers in our study. Three
studies (22%) [1, 12, 19] had a follow up of only two
years. It could be argued that this might underestimate
the prevalence of osteonecrosis; however, two years has
been used as an outcome in previous research [9] and is
perhaps acceptable for making reasonable inferences.
There was variation in the radiological classifications
used for grading the severity of osteonecrosis in dif-
ferent studies. Thirteen studies (93%) used Bucholz
and Ogden [1, 3, 6–8, 13, 14, 16] or Kalamchi and
MacEwen [2, 4, 5, 12, 20] which are interchangeable.
Madhu et al. [19] graded osteonecrosis according to
Salter et al. [23] and we thus could include their data
only when modeling the effects of the ossific nucleus
on osteonecrosis of grades I–IV.
Conclusion
Based on current evidence there does not appear to be a
protective effect of the ossific nucleus on the develop-
ment of osteonecrosis. In contrast to the previous meta-
analysis, this update demonstrates that this remains the
case irrespective of the grade of osteonecrosis consid-
ered relevant. This updated meta-analysis is based on
twice as many studies with a higher quality of evidence
and therefore provides more robust conclusions. There
does appear to be a protective effect against the develop-
ment of grade II-IV osteonecrosis when closed reduc-
tions are performed. Caution must be exercised as the
number of studies on which this conclusion is based is
small and the clinical implication is unclear since the
likelihood of successful closed reduction reduces with
time. We therefore conclude that the practice of delay-
ing open reduction until the appearance of the femoral
ossific nucleus is not currently supported by the
Fig. 6 Forest plot for the development of osteonecrosis of any grade at two or more years following closed reduction. Including the data of
seven studies, 684 hips were analyzed. There was no statistically significant association between the ossific nucleus and the development
of osteonecrosis
Fig. 7 Forest plot for the development of osteonecrosis of any grade at two or more years following open reduction. Including the data of six studies,
258 hips were analyzed. There was no statistically significant association between the ossific nucleus and the development of osteonecrosis
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literature. However this meta-analysis is based on exclu-
sively retrospective studies and the quality of evidence
remains moderate. It is the opinion of these authors that
the question of whether delaying the treatment of a dis-
located hip in the absence of the ossific nucleus can
mitigate the risk for osteonecrosis would be best an-
swered by a randomized clinical trial.
Additional file
Additional file 1: Forest plots showing a fixed or random effects models
equivalent to Figs. 2, 3, 4, 5, 6 and 7. a. Data used in Fig. 2 analysed using a
fixed effects model. b. Data used in Fig. 3 analyzed using a random effects
model. c. Data used in Fig. 4 analyzed using a random effects model. d.
Data used in Fig. 5 analyzed using a random effects model. e. Data used in
Fig. 6 analyzed using a random effects model. f. Data used in Fig. 7 analyzed
using a random effects model. (DOCX 79 kb)
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